Audentes Therapeutics To Present At Piper Jaffray Healthcare Conference

SAN FRANCISCO--(BUSINESS WIRE)--Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced that Matthew Patterson, President and Chief Executive Officer, will present a corporate overview at the 26th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, December 2, 2014 at 12:30pm Eastern.

Help employers find you! Check out all the jobs and post your resume.